Stocks›Healthcare›DERM

DERM

Journey Medical Corp

NasdaqResearch view

$6.14−2.85%

Sep 25 close · 1D EOD · Databento

HealthcarePharmaceutical PreparationsMicro-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around mid November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 12, 2025 and Nov 12, 2024, after the close.

Last report

Aug 12, 2026+3.42%

after the close

Last 4, next close

median 18.83% either way

up 2 of 4

Every report since 2023 →

DateEventSourceNext close

Aug 12Earnings release, after the close · 8-KSEC EDGARSEC EDGAR ↗+3.42%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

Big days · last year

Daily closes · Databento EOD

18 big days: a close more than 6.27% from the one before, three times DERM’s median day (2.09%). On 1 of 18, its largest peers moved the same way at least half as far. We show what we hold, never a cause.

Shaded: since our stories began, May 26, 2026

18Sep 23, 2026
Sep 23, 2026Nothing in our recordNo DERM story, brief or results filing in our record that dayGroup −0.8% did not move with it
−0.8% did not move with itMRK −1.9 · LLY −1.6 · ABBV −0.1 · JNJ −0.0
−10.34%
17Sep 9, 2026
Sep 9, 2026Nothing in our recordNo DERM story, brief or results filing in our record that dayGroup −0.3% did not move with it
−0.3% did not move with itABBV +0.9 · JNJ −0.8 · MRK −0.6 · LLY +0.0
−6.52%
16Aug 20, 2026
Aug 20, 2026Nothing in our recordNo DERM story, brief or results filing in our record that dayGroup −2.2% did not move with it
−2.2% did not move with itLLY −2.8 · JNJ −2.2 · MRK −2.1 · ABBV −1.6
+9.99%
15Jul 23, 2026
Jul 23, 2026Nothing in our recordNo DERM story, brief or results filing in our record that dayGroup +1.7% did not move with it
+1.7% did not move with itMRK +2.4 · LLY +2.0 · ABBV +1.4 · JNJ +1.4
−7.58%
14Jul 7, 2026
Jul 7, 2026Nothing in our recordNo DERM story, brief or results filing in our record that dayGroup +2.3% did not move with it
+2.3% did not move with itJNJ +3.0 · LLY +3.0 · MRK +1.6 · ABBV −0.0
−6.58%
13Jun 26, 2026
Jun 26, 2026Nothing in our recordNo DERM story, brief or results filing in our record that dayGroup +4.1% moved the same way
+4.1% moved the same wayLLY +7.1 · ABBV +4.2 · JNJ +4.0 · MRK +2.6
+6.43%
12Jun 25, 2026
Jun 25, 2026Nothing in our recordNo DERM story, brief or results filing in our record that dayGroup +2.6% did not move with it
+2.6% did not move with itMRK +4.0 · ABBV +3.5 · JNJ +1.6 · LLY +0.9
−9.20%
11May 14, 2026
May 14, 2026ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group +0.1% did not move with it
+0.1% did not move with itABBV +1.1 · LLY −0.9 · JNJ +0.2 · MRK −0.0
+22.35%
10Apr 8, 2026
Apr 8, 2026Before our storiesGroup +2.5% did not move with it
+2.5% did not move with itMRK +3.3 · ABBV +2.5 · LLY +2.4 · JNJ +1.2
+7.68%
9Apr 2, 2026
Apr 2, 2026Before our storiesGroup −1.2% did not move with it
−1.2% did not move with itABBV −2.9 · LLY −2.0 · JNJ −0.4 · MRK +0.0
+6.68%
8Mar 31, 2026
Mar 31, 2026Before our storiesGroup +1.9% did not move with it
+1.9% did not move with itLLY +3.7 · ABBV +2.0 · MRK +1.9 · JNJ +0.8
+6.83%
7Mar 26, 2026
Mar 26, 2026ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group −0.3% did not move with it
−0.3% did not move with itLLY −2.1 · ABBV +1.9 · MRK −0.4 · JNJ −0.3
−30.01%
6Mar 13, 2026
Mar 13, 2026Before our storiesGroup −0.2% did not move with it
−0.2% did not move with itABBV −2.5 · LLY +0.8 · MRK −0.3 · JNJ −0.2
−6.96%
5Jan 20, 2026
Jan 20, 2026Before our storiesGroup +0.1% did not move with it
+0.1% did not move with itMRK +0.6 · LLY +0.3 · JNJ −0.2 · ABBV −0.1
+8.99%
4Jan 15, 2026
Jan 15, 2026Before our storiesGroup −1.2% did not move with it
−1.2% did not move with itLLY −3.8 · ABBV −2.3 · JNJ +0.5 · MRK −0.0
+6.63%
3Jan 12, 2026
Jan 12, 2026Before our storiesGroup +0.8% did not move with it
+0.8% did not move with itJNJ +2.6 · LLY +1.6 · MRK −1.2 · ABBV −0.0
+6.46%
2Nov 13, 2025
Nov 13, 2025ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group +0.5% did not move with it
+0.5% did not move with itMRK +1.6 · LLY +0.5 · JNJ +0.4 · ABBV −0.4
−15.31%
1Oct 27, 2025
Oct 27, 2025Before our storiesGroup +0.1% did not move with it
+0.1% did not move with itMRK +0.6 · LLY +0.1 · JNJ −0.1 · ABBV +0.0
+7.51%

A story on the same day is not a cause, and a group move is not proof either. Group: LLY, JNJ, ABBV, MRK, the largest companies in DERM’s SEC industry; “the same way” means the same direction and at least half as far. Prior-session closes only; not a call, not advice.

The numbers · FY2025, filed

SEC EDGAR

Market cap$150M

Revenue$61.9M+10.20%

Net income$-11.4M

EPS, diluted$-0.47+34.70%

Operating margin-13.2%

Return on equity-35.9%

Debt / equity0.97

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$150.4M

Enterprise Value$157.2M

Income$-11.4M

Sales$61.9M

Book/sh—

Cash/sh—

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio1.53

Current Ratio1.79

Debt/Eq0.97

EPS (ttm)$-0.47

EPS this Y34.7%

EPS past 3/5Y—

Sales past 3/5Y-5.7%

EPS Y/Y TTM34.7%

Sales Y/Y TTM10.2%

Shs Outstand—

ROA-12.1%

ROE-35.9%

ROIC-21.2%

Gross Margin—

Oper. Margin-13.2%

Profit Margin-18.5%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$63.1M

FY21

$73.7M

FY22

$79.2M

FY23

$56.1M

FY24

$61.9M

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$63.1M	$73.7M	$79.2M	$56.1M	$61.9M
Gross Profit	—	—	—	—	—
Operating Income	$-34.9M	$-27.5M	$-2.1M	$-13.7M	$-8.2M
Net Income	$-44.0M	$-29.6M	$-3.9M	$-14.7M	$-11.4M
Diluted EPS	$-4.32	$-1.69	$-0.21	$-0.72	$-0.47
Operating Cash Flow	$-2.2M	$-13.5M	$5.2M	$-9.1M	$-12.4M
Free Cash Flow	—	—	—	—	—

Same industry

In the screener →

LLY$1.11T JNJ$653.6B ABBV$467.1B MRK$367.1B ABT$175.3B PFE$163.4B VRTX$133.4B BMY$128.4B

Build basket with DERM Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.